MAPK8 and diabetes mellitus: Both Ins2Akita-JNK1-/- mice and STZDM-JNK1-/- mice demonstrated a significant decrease in serum NO levels compared with those in Ins2Akita mice and JNK1-/-DM mice, respectively.